Zhu W - Search Results

1

Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling.

Zheng M, Zhu W, Han Q, Xiao RP. Zheng M, et al. Among authors: zhu w. Pharmacol Ther. 2005 Dec;108(3):257-68. doi: 10.1016/j.pharmthera.2005.04.006. Epub 2005 Jun 24. Pharmacol Ther. 2005. PMID: 15979723 Review.

2

Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart.

Xiao RP, Zhu W, Zheng M, Cao C, Zhang Y, Lakatta EG, Han Q. Xiao RP, et al. Among authors: zhu w. Trends Pharmacol Sci. 2006 Jun;27(6):330-7. doi: 10.1016/j.tips.2006.04.009. Epub 2006 May 11. Trends Pharmacol Sci. 2006. PMID: 16697055 Review.

3

Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.

Woo AY, Song Y, Xiao RP, Zhu W. Woo AY, et al. Among authors: zhu w. Br J Pharmacol. 2015 Dec;172(23):5444-56. doi: 10.1111/bph.12965. Epub 2014 Dec 17. Br J Pharmacol. 2015. PMID: 25298054 Free PMC article. Review.

4

beta 2-adrenergic receptor-induced p38 MAPK activation is mediated by protein kinase A rather than by Gi or gbeta gamma in adult mouse cardiomyocytes.

Zheng M, Zhang SJ, Zhu WZ, Ziman B, Kobilka BK, Xiao RP. Zheng M, et al. Among authors: zhu wz. J Biol Chem. 2000 Dec 22;275(51):40635-40. doi: 10.1074/jbc.M006325200. J Biol Chem. 2000. PMID: 11018034 Free article.

5

Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes.

Zhu WZ, Zheng M, Koch WJ, Lefkowitz RJ, Kobilka BK, Xiao RP. Zhu WZ, et al. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1607-12. doi: 10.1073/pnas.98.4.1607. Proc Natl Acad Sci U S A. 2001. PMID: 11171998 Free PMC article.

6

Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.

Xiao RP, Zhang SJ, Chakir K, Avdonin P, Zhu W, Bond RA, Balke CW, Lakatta EG, Cheng H. Xiao RP, et al. Among authors: zhu w. Circulation. 2003 Sep 30;108(13):1633-9. doi: 10.1161/01.CIR.0000087595.17277.73. Epub 2003 Sep 15. Circulation. 2003. PMID: 12975249

7

Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications.

Xiao RP, Zhu W, Zheng M, Chakir K, Bond R, Lakatta EG, Cheng H. Xiao RP, et al. Among authors: zhu w. Trends Pharmacol Sci. 2004 Jul;25(7):358-65. doi: 10.1016/j.tips.2004.05.007. Trends Pharmacol Sci. 2004. PMID: 15219978 Review. No abstract available.

8

Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway.

Wang W, Zhu W, Wang S, Yang D, Crow MT, Xiao RP, Cheng H. Wang W, et al. Among authors: zhu w. Circ Res. 2004 Oct 15;95(8):798-806. doi: 10.1161/01.RES.0000145361.50017.aa. Epub 2004 Sep 16. Circ Res. 2004. PMID: 15375008

9

The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly.

Zhu W, Zeng X, Zheng M, Xiao RP. Zhu W, et al. Circ Res. 2005 Sep 16;97(6):507-9. doi: 10.1161/01.RES.0000184615.56822.bd. Circ Res. 2005. PMID: 16166560 No abstract available.

10

Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis.

Zhu W, Woo AY, Yang D, Cheng H, Crow MT, Xiao RP. Zhu W, et al. J Biol Chem. 2007 Apr 6;282(14):10833-9. doi: 10.1074/jbc.M611507200. Epub 2007 Feb 12. J Biol Chem. 2007. PMID: 17296607 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,015 results

Search Page

Filters